DMRA
Damora Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.59
−0.83%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$22.94
From 52W high−33.83%
Volume3.02M
Market cap$1.39B
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$22.94
From 52W high
−33.83%
Volume
3.02M
Market cap
$1.39B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.7x
P/E (TTM)
—
RSI (14)
33.5
MomentumView details →
1D Return
−0.83%
YTD Return
+1.43%
Similar companies
Latest newsMore news →
No recent news for DMRA.